SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-017685
Filing Date
2022-06-21
Accepted
2022-06-21 16:59:18
Documents
12
Period of Report
2022-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K bvs-20220617.htm   iXBRL 8-K 46099
  Complete submission text file 0001628280-22-017685.txt   190022

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bvs-20220617.xsd EX-101.SCH 1902
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bvs-20220617_lab.xml EX-101.LAB 25848
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bvs-20220617_pre.xml EX-101.PRE 13582
6 EXTRACTED XBRL INSTANCE DOCUMENT bvs-20220617_htm.xml XML 11439
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

IRS No.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 221028824
SIC: 3841 Surgical & Medical Instruments & Apparatus